Academics
Admissions
Hunter College Schools
| Description: |
For years, the foundations of cancer treatment were surgery, chemotherapy, and radiation therapy. Over the last two decades, targeted therapies are drugs that target cancer cells by homing in on specific molecular changes seen primarily in those cells have also cemented themselves as standard treatments for many cancers. But over the past several years, immunotherapy—therapies that enlist and strengthen the power of a patient’s immune system to attack tumors—has emerged as what many in the cancer community. In 2017, two CAR T-cell therapies were approved by the Food and Drug Administration (FDA), one for the treatment of children with acute lymphoblastic leukemia (ALL) and the other for adults with advanced lymphomas. Nevertheless, researchers caution that, in many respects, it’s still early days for CAR T cells, including questions about whether they will ever be effective against solid tumors. Join us for a discussion on immunotherapy, specifically CAR T Cell immunotherapy. Please review the materials below before the discussion. https://soundcloud.com/user-330134924/how_car_t_work |
| Category: | Pre-Professional Advising |
| Contact Email: | prehealth@hunter.cuny.edu |
| Begins: | 26 Feb 2019 12:00 PM ET |
| Ends: | 26 Feb 2019 01:00 PM ET |
| Location: | Hunter East 710 |
| Address: |
7th floor East building (by the bridge) Pre-Professional Advising Center Conference room |
| Additional Details: | |
| Status: | This event has passed. |
Please view the Anthology Privacy Policy to learn more about our policies and practices regarding the use and disclosure of the personal information you provide.